Global Long-acting Insulin Glargine Market Research Report 2026(Status and Outlook)
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Long-acting Insulin Glargine competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.Long-acting insulin glargine is a modified form of human insulin designed to provide a prolonged and steady release of insulin over approximately 24 hours. It helps maintain basal insulin levels in patients with diabetes mellitus, reducing the risk of blood sugar fluctuations between meals and overnight. Its unique formulation allows for once-daily dosing with minimal peak activity.
The global Long-acting Insulin Glargine market size was estimated at USD 8124.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of -2.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Long-acting Insulin Glargine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Long-acting Insulin Glargine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Long-acting Insulin Glargine market.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Insulin Glargine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting Insulin Glargine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
The global Long-acting Insulin Glargine market size was estimated at USD 8124.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of -2.40% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Long-acting Insulin Glargine market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Long-acting Insulin Glargine market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Long-acting Insulin Glargine market.
Global Long-acting Insulin Glargine Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
- Sanofi
- Eli Lilly & Co
- Biocon Biologics
- Gan & Lee
- Tonghua Dongbao
- Biocare
- United Laboratories
- KALBE PHARMA
- Swixx Biopharma
- INFION PHARMA
- Viatris
- Wockhardt
- Lupin Laboratories
- Cipla
Market Segmentation (by Type)
- Vial
- Prefilled
Market Segmentation (by Application)
- Type 1 Diabetes
- Type 2 Diabetes
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Long-acting Insulin Glargine Market
Overview of the regional outlook of the Long-acting Insulin Glargine Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Long-acting Insulin Glargine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Long-acting Insulin Glargine, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Long-acting Insulin Glargine
1.2 Key Market Segments
1.2.1 Long-acting Insulin Glargine Segment by Type
1.2.2 Long-acting Insulin Glargine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING INSULIN GLARGINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Insulin Glargine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Long-acting Insulin Glargine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING INSULIN GLARGINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting Insulin Glargine Product Life Cycle
3.3 Global Long-acting Insulin Glargine Sales by Manufacturers (2020-2025)
3.4 Global Long-acting Insulin Glargine Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting Insulin Glargine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting Insulin Glargine Market Competitive Situation and Trends
3.8.1 Long-acting Insulin Glargine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting Insulin Glargine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING INSULIN GLARGINE INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Insulin Glargine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING INSULIN GLARGINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting Insulin Glargine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting Insulin Glargine Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING INSULIN GLARGINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Insulin Glargine Sales Market Share by Type (2020-2025)
6.3 Global Long-acting Insulin Glargine Market Size by Type (2020-2025)
6.4 Global Long-acting Insulin Glargine Price by Type (2020-2025)
7 LONG-ACTING INSULIN GLARGINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Insulin Glargine Market Sales by Application (2020-2025)
7.3 Global Long-acting Insulin Glargine Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING INSULIN GLARGINE MARKET SALES BY REGION
8.1 Global Long-acting Insulin Glargine Sales by Region
8.1.1 Global Long-acting Insulin Glargine Sales by Region
8.1.2 Global Long-acting Insulin Glargine Sales Market Share by Region
8.2 Global Long-acting Insulin Glargine Market Size by Region
8.2.1 Global Long-acting Insulin Glargine Market Size by Region
8.2.2 Global Long-acting Insulin Glargine Market Size by Region
8.3 North America
8.3.1 North America Long-acting Insulin Glargine Sales by Country
8.3.2 North America Long-acting Insulin Glargine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting Insulin Glargine Sales by Country
8.4.2 Europe Long-acting Insulin Glargine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting Insulin Glargine Sales by Region
8.5.2 Asia Pacific Long-acting Insulin Glargine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting Insulin Glargine Sales by Country
8.6.2 South America Long-acting Insulin Glargine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting Insulin Glargine Sales by Region
8.7.2 Middle East and Africa Long-acting Insulin Glargine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING INSULIN GLARGINE MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting Insulin Glargine by Region(2020-2025)
9.2 Global Long-acting Insulin Glargine Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting Insulin Glargine Production
9.4.1 North America Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.4.2 North America Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting Insulin Glargine Production
9.5.1 Europe Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting Insulin Glargine Production (2020-2025)
9.6.1 Japan Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting Insulin Glargine Production (2020-2025)
9.7.1 China Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.7.2 China Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Long-acting Insulin Glargine Product Overview
10.1.3 Sanofi Long-acting Insulin Glargine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Eli Lilly and Co
10.2.1 Eli Lilly and Co Basic Information
10.2.2 Eli Lilly and Co Long-acting Insulin Glargine Product Overview
10.2.3 Eli Lilly and Co Long-acting Insulin Glargine Product Market Performance
10.2.4 Eli Lilly and Co Business Overview
10.2.5 Eli Lilly and Co SWOT Analysis
10.2.6 Eli Lilly and Co Recent Developments
10.3 Biocon Biologics
10.3.1 Biocon Biologics Basic Information
10.3.2 Biocon Biologics Long-acting Insulin Glargine Product Overview
10.3.3 Biocon Biologics Long-acting Insulin Glargine Product Market Performance
10.3.4 Biocon Biologics Business Overview
10.3.5 Biocon Biologics SWOT Analysis
10.3.6 Biocon Biologics Recent Developments
10.4 Gan and Lee
10.4.1 Gan and Lee Basic Information
10.4.2 Gan and Lee Long-acting Insulin Glargine Product Overview
10.4.3 Gan and Lee Long-acting Insulin Glargine Product Market Performance
10.4.4 Gan and Lee Business Overview
10.4.5 Gan and Lee Recent Developments
10.5 Tonghua Dongbao
10.5.1 Tonghua Dongbao Basic Information
10.5.2 Tonghua Dongbao Long-acting Insulin Glargine Product Overview
10.5.3 Tonghua Dongbao Long-acting Insulin Glargine Product Market Performance
10.5.4 Tonghua Dongbao Business Overview
10.5.5 Tonghua Dongbao Recent Developments
10.6 Biocare
10.6.1 Biocare Basic Information
10.6.2 Biocare Long-acting Insulin Glargine Product Overview
10.6.3 Biocare Long-acting Insulin Glargine Product Market Performance
10.6.4 Biocare Business Overview
10.6.5 Biocare Recent Developments
10.7 United Laboratories
10.7.1 United Laboratories Basic Information
10.7.2 United Laboratories Long-acting Insulin Glargine Product Overview
10.7.3 United Laboratories Long-acting Insulin Glargine Product Market Performance
10.7.4 United Laboratories Business Overview
10.7.5 United Laboratories Recent Developments
10.8 KALBE PHARMA
10.8.1 KALBE PHARMA Basic Information
10.8.2 KALBE PHARMA Long-acting Insulin Glargine Product Overview
10.8.3 KALBE PHARMA Long-acting Insulin Glargine Product Market Performance
10.8.4 KALBE PHARMA Business Overview
10.8.5 KALBE PHARMA Recent Developments
10.9 Swixx Biopharma
10.9.1 Swixx Biopharma Basic Information
10.9.2 Swixx Biopharma Long-acting Insulin Glargine Product Overview
10.9.3 Swixx Biopharma Long-acting Insulin Glargine Product Market Performance
10.9.4 Swixx Biopharma Business Overview
10.9.5 Swixx Biopharma Recent Developments
10.10 INFION PHARMA
10.10.1 INFION PHARMA Basic Information
10.10.2 INFION PHARMA Long-acting Insulin Glargine Product Overview
10.10.3 INFION PHARMA Long-acting Insulin Glargine Product Market Performance
10.10.4 INFION PHARMA Business Overview
10.10.5 INFION PHARMA Recent Developments
10.11 Viatris
10.11.1 Viatris Basic Information
10.11.2 Viatris Long-acting Insulin Glargine Product Overview
10.11.3 Viatris Long-acting Insulin Glargine Product Market Performance
10.11.4 Viatris Business Overview
10.11.5 Viatris Recent Developments
10.12 Wockhardt
10.12.1 Wockhardt Basic Information
10.12.2 Wockhardt Long-acting Insulin Glargine Product Overview
10.12.3 Wockhardt Long-acting Insulin Glargine Product Market Performance
10.12.4 Wockhardt Business Overview
10.12.5 Wockhardt Recent Developments
10.13 Lupin Laboratories
10.13.1 Lupin Laboratories Basic Information
10.13.2 Lupin Laboratories Long-acting Insulin Glargine Product Overview
10.13.3 Lupin Laboratories Long-acting Insulin Glargine Product Market Performance
10.13.4 Lupin Laboratories Business Overview
10.13.5 Lupin Laboratories Recent Developments
10.14 Cipla
10.14.1 Cipla Basic Information
10.14.2 Cipla Long-acting Insulin Glargine Product Overview
10.14.3 Cipla Long-acting Insulin Glargine Product Market Performance
10.14.4 Cipla Business Overview
10.14.5 Cipla Recent Developments
11 LONG-ACTING INSULIN GLARGINE MARKET FORECAST BY REGION
11.1 Global Long-acting Insulin Glargine Market Size Forecast
11.2 Global Long-acting Insulin Glargine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting Insulin Glargine Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting Insulin Glargine Market Size Forecast by Region
11.2.4 South America Long-acting Insulin Glargine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting Insulin Glargine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Long-acting Insulin Glargine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Long-acting Insulin Glargine by Type (2026-2035)
12.1.2 Global Long-acting Insulin Glargine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Long-acting Insulin Glargine by Type (2026-2035)
12.2 Global Long-acting Insulin Glargine Market Forecast by Application (2026-2035)
12.2.1 Global Long-acting Insulin Glargine Sales (K MT) Forecast by Application
12.2.2 Global Long-acting Insulin Glargine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Long-acting Insulin Glargine
1.2 Key Market Segments
1.2.1 Long-acting Insulin Glargine Segment by Type
1.2.2 Long-acting Insulin Glargine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 LONG-ACTING INSULIN GLARGINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Long-acting Insulin Glargine Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Long-acting Insulin Glargine Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 LONG-ACTING INSULIN GLARGINE MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Long-acting Insulin Glargine Product Life Cycle
3.3 Global Long-acting Insulin Glargine Sales by Manufacturers (2020-2025)
3.4 Global Long-acting Insulin Glargine Revenue Market Share by Manufacturers (2020-2025)
3.5 Long-acting Insulin Glargine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Long-acting Insulin Glargine Average Price by Manufacturers (2020-2025)
3.7 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
3.8 Long-acting Insulin Glargine Market Competitive Situation and Trends
3.8.1 Long-acting Insulin Glargine Market Concentration Rate
3.8.2 Global 5 and 10 Largest Long-acting Insulin Glargine Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 LONG-ACTING INSULIN GLARGINE INDUSTRY CHAIN ANALYSIS
4.1 Long-acting Insulin Glargine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF LONG-ACTING INSULIN GLARGINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Long-acting Insulin Glargine Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy – April 2025
5.6.3 Global Trade Frictions and Their Impacts to Long-acting Insulin Glargine Market
5.7 ESG Ratings of Leading Companies
6 LONG-ACTING INSULIN GLARGINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Long-acting Insulin Glargine Sales Market Share by Type (2020-2025)
6.3 Global Long-acting Insulin Glargine Market Size by Type (2020-2025)
6.4 Global Long-acting Insulin Glargine Price by Type (2020-2025)
7 LONG-ACTING INSULIN GLARGINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Long-acting Insulin Glargine Market Sales by Application (2020-2025)
7.3 Global Long-acting Insulin Glargine Market Size (M USD) by Application (2020-2025)
7.4 Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
8 LONG-ACTING INSULIN GLARGINE MARKET SALES BY REGION
8.1 Global Long-acting Insulin Glargine Sales by Region
8.1.1 Global Long-acting Insulin Glargine Sales by Region
8.1.2 Global Long-acting Insulin Glargine Sales Market Share by Region
8.2 Global Long-acting Insulin Glargine Market Size by Region
8.2.1 Global Long-acting Insulin Glargine Market Size by Region
8.2.2 Global Long-acting Insulin Glargine Market Size by Region
8.3 North America
8.3.1 North America Long-acting Insulin Glargine Sales by Country
8.3.2 North America Long-acting Insulin Glargine Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Long-acting Insulin Glargine Sales by Country
8.4.2 Europe Long-acting Insulin Glargine Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Long-acting Insulin Glargine Sales by Region
8.5.2 Asia Pacific Long-acting Insulin Glargine Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Long-acting Insulin Glargine Sales by Country
8.6.2 South America Long-acting Insulin Glargine Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Long-acting Insulin Glargine Sales by Region
8.7.2 Middle East and Africa Long-acting Insulin Glargine Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 LONG-ACTING INSULIN GLARGINE MARKET PRODUCTION BY REGION
9.1 Global Production of Long-acting Insulin Glargine by Region(2020-2025)
9.2 Global Long-acting Insulin Glargine Revenue Market Share by Region (2020-2025)
9.3 Global Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Long-acting Insulin Glargine Production
9.4.1 North America Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.4.2 North America Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Long-acting Insulin Glargine Production
9.5.1 Europe Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.5.2 Europe Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Long-acting Insulin Glargine Production (2020-2025)
9.6.1 Japan Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.6.2 Japan Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Long-acting Insulin Glargine Production (2020-2025)
9.7.1 China Long-acting Insulin Glargine Production Growth Rate (2020-2025)
9.7.2 China Long-acting Insulin Glargine Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Sanofi
10.1.1 Sanofi Basic Information
10.1.2 Sanofi Long-acting Insulin Glargine Product Overview
10.1.3 Sanofi Long-acting Insulin Glargine Product Market Performance
10.1.4 Sanofi Business Overview
10.1.5 Sanofi SWOT Analysis
10.1.6 Sanofi Recent Developments
10.2 Eli Lilly and Co
10.2.1 Eli Lilly and Co Basic Information
10.2.2 Eli Lilly and Co Long-acting Insulin Glargine Product Overview
10.2.3 Eli Lilly and Co Long-acting Insulin Glargine Product Market Performance
10.2.4 Eli Lilly and Co Business Overview
10.2.5 Eli Lilly and Co SWOT Analysis
10.2.6 Eli Lilly and Co Recent Developments
10.3 Biocon Biologics
10.3.1 Biocon Biologics Basic Information
10.3.2 Biocon Biologics Long-acting Insulin Glargine Product Overview
10.3.3 Biocon Biologics Long-acting Insulin Glargine Product Market Performance
10.3.4 Biocon Biologics Business Overview
10.3.5 Biocon Biologics SWOT Analysis
10.3.6 Biocon Biologics Recent Developments
10.4 Gan and Lee
10.4.1 Gan and Lee Basic Information
10.4.2 Gan and Lee Long-acting Insulin Glargine Product Overview
10.4.3 Gan and Lee Long-acting Insulin Glargine Product Market Performance
10.4.4 Gan and Lee Business Overview
10.4.5 Gan and Lee Recent Developments
10.5 Tonghua Dongbao
10.5.1 Tonghua Dongbao Basic Information
10.5.2 Tonghua Dongbao Long-acting Insulin Glargine Product Overview
10.5.3 Tonghua Dongbao Long-acting Insulin Glargine Product Market Performance
10.5.4 Tonghua Dongbao Business Overview
10.5.5 Tonghua Dongbao Recent Developments
10.6 Biocare
10.6.1 Biocare Basic Information
10.6.2 Biocare Long-acting Insulin Glargine Product Overview
10.6.3 Biocare Long-acting Insulin Glargine Product Market Performance
10.6.4 Biocare Business Overview
10.6.5 Biocare Recent Developments
10.7 United Laboratories
10.7.1 United Laboratories Basic Information
10.7.2 United Laboratories Long-acting Insulin Glargine Product Overview
10.7.3 United Laboratories Long-acting Insulin Glargine Product Market Performance
10.7.4 United Laboratories Business Overview
10.7.5 United Laboratories Recent Developments
10.8 KALBE PHARMA
10.8.1 KALBE PHARMA Basic Information
10.8.2 KALBE PHARMA Long-acting Insulin Glargine Product Overview
10.8.3 KALBE PHARMA Long-acting Insulin Glargine Product Market Performance
10.8.4 KALBE PHARMA Business Overview
10.8.5 KALBE PHARMA Recent Developments
10.9 Swixx Biopharma
10.9.1 Swixx Biopharma Basic Information
10.9.2 Swixx Biopharma Long-acting Insulin Glargine Product Overview
10.9.3 Swixx Biopharma Long-acting Insulin Glargine Product Market Performance
10.9.4 Swixx Biopharma Business Overview
10.9.5 Swixx Biopharma Recent Developments
10.10 INFION PHARMA
10.10.1 INFION PHARMA Basic Information
10.10.2 INFION PHARMA Long-acting Insulin Glargine Product Overview
10.10.3 INFION PHARMA Long-acting Insulin Glargine Product Market Performance
10.10.4 INFION PHARMA Business Overview
10.10.5 INFION PHARMA Recent Developments
10.11 Viatris
10.11.1 Viatris Basic Information
10.11.2 Viatris Long-acting Insulin Glargine Product Overview
10.11.3 Viatris Long-acting Insulin Glargine Product Market Performance
10.11.4 Viatris Business Overview
10.11.5 Viatris Recent Developments
10.12 Wockhardt
10.12.1 Wockhardt Basic Information
10.12.2 Wockhardt Long-acting Insulin Glargine Product Overview
10.12.3 Wockhardt Long-acting Insulin Glargine Product Market Performance
10.12.4 Wockhardt Business Overview
10.12.5 Wockhardt Recent Developments
10.13 Lupin Laboratories
10.13.1 Lupin Laboratories Basic Information
10.13.2 Lupin Laboratories Long-acting Insulin Glargine Product Overview
10.13.3 Lupin Laboratories Long-acting Insulin Glargine Product Market Performance
10.13.4 Lupin Laboratories Business Overview
10.13.5 Lupin Laboratories Recent Developments
10.14 Cipla
10.14.1 Cipla Basic Information
10.14.2 Cipla Long-acting Insulin Glargine Product Overview
10.14.3 Cipla Long-acting Insulin Glargine Product Market Performance
10.14.4 Cipla Business Overview
10.14.5 Cipla Recent Developments
11 LONG-ACTING INSULIN GLARGINE MARKET FORECAST BY REGION
11.1 Global Long-acting Insulin Glargine Market Size Forecast
11.2 Global Long-acting Insulin Glargine Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Long-acting Insulin Glargine Market Size Forecast by Country
11.2.3 Asia Pacific Long-acting Insulin Glargine Market Size Forecast by Region
11.2.4 South America Long-acting Insulin Glargine Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Long-acting Insulin Glargine by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Long-acting Insulin Glargine Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Long-acting Insulin Glargine by Type (2026-2035)
12.1.2 Global Long-acting Insulin Glargine Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Long-acting Insulin Glargine by Type (2026-2035)
12.2 Global Long-acting Insulin Glargine Market Forecast by Application (2026-2035)
12.2.1 Global Long-acting Insulin Glargine Sales (K MT) Forecast by Application
12.2.2 Global Long-acting Insulin Glargine Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Long-acting Insulin Glargine Market Size by Type (M USD)
Table 4. Global Long-acting Insulin Glargine Market Size by Application
Table 5. Long-acting Insulin Glargine Market Size Comparison by Region (M USD)
Table 6. Global Long-acting Insulin Glargine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Long-acting Insulin Glargine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Long-acting Insulin Glargine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Long-acting Insulin Glargine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Insulin Glargine as of 2025)
Table 11. Global Market Long-acting Insulin Glargine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Long-acting Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting Insulin Glargine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Long-acting Insulin Glargine Sales by Type (K MT)
Table 27. Global Long-acting Insulin Glargine Market Size by Type (M USD)
Table 28. Global Long-acting Insulin Glargine Sales (K MT) by Type (2020-2025)
Table 29. Global Long-acting Insulin Glargine Sales Market Share by Type (2020-2025)
Table 30. Global Long-acting Insulin Glargine Market Size (M USD) by Type (2020-2025)
Table 31. Global Long-acting Insulin Glargine Market Share by Type (2020-2025)
Table 32. Global Long-acting Insulin Glargine Price (USD/KG) by Type (2020-2025)
Table 33. Global Long-acting Insulin Glargine Sales (K MT) by Application
Table 34. Global Long-acting Insulin Glargine Market Size by Application
Table 35. Global Long-acting Insulin Glargine Sales by Application (2020-2025) & (K MT)
Table 36. Global Long-acting Insulin Glargine Sales Market Share by Application (2020-2025)
Table 37. Global Long-acting Insulin Glargine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Long-acting Insulin Glargine Market Share by Application (2020-2025)
Table 39. Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
Table 40. Global Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 41. Global Long-acting Insulin Glargine Sales Market Share by Region (2020-2025)
Table 42. Global Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Long-acting Insulin Glargine Market Size by Region (2020-2025)
Table 44. North America Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 45. North America Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 51. South America Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Long-acting Insulin Glargine Production (K MT) by Region(2020-2025)
Table 55. Global Long-acting Insulin Glargine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Long-acting Insulin Glargine Revenue Market Share by Region (2020-2025)
Table 57. Global Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Long-acting Insulin Glargine Product Overview
Table 64. Sanofi Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Eli Lilly and Co Basic Information
Table 69. Eli Lilly and Co Long-acting Insulin Glargine Product Overview
Table 70. Eli Lilly and Co Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly and Co Business Overview
Table 72. Eli Lilly and Co SWOT Analysis
Table 73. Eli Lilly and Co Recent Developments
Table 74. Biocon Biologics Basic Information
Table 75. Biocon Biologics Long-acting Insulin Glargine Product Overview
Table 76. Biocon Biologics Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Biocon Biologics Business Overview
Table 78. Biocon Biologics SWOT Analysis
Table 79. Biocon Biologics Recent Developments
Table 80. Gan and Lee Basic Information
Table 81. Gan and Lee Long-acting Insulin Glargine Product Overview
Table 82. Gan and Lee Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Gan and Lee Business Overview
Table 84. Gan and Lee Recent Developments
Table 85. Tonghua Dongbao Basic Information
Table 86. Tonghua Dongbao Long-acting Insulin Glargine Product Overview
Table 87. Tonghua Dongbao Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tonghua Dongbao Business Overview
Table 89. Tonghua Dongbao Recent Developments
Table 90. Biocare Basic Information
Table 91. Biocare Long-acting Insulin Glargine Product Overview
Table 92. Biocare Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Biocare Business Overview
Table 94. Biocare Recent Developments
Table 95. United Laboratories Basic Information
Table 96. United Laboratories Long-acting Insulin Glargine Product Overview
Table 97. United Laboratories Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. United Laboratories Business Overview
Table 99. United Laboratories Recent Developments
Table 100. KALBE PHARMA Basic Information
Table 101. KALBE PHARMA Long-acting Insulin Glargine Product Overview
Table 102. KALBE PHARMA Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KALBE PHARMA Business Overview
Table 104. KALBE PHARMA Recent Developments
Table 105. Swixx Biopharma Basic Information
Table 106. Swixx Biopharma Long-acting Insulin Glargine Product Overview
Table 107. Swixx Biopharma Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Swixx Biopharma Business Overview
Table 109. Swixx Biopharma Recent Developments
Table 110. INFION PHARMA Basic Information
Table 111. INFION PHARMA Long-acting Insulin Glargine Product Overview
Table 112. INFION PHARMA Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. INFION PHARMA Business Overview
Table 114. INFION PHARMA Recent Developments
Table 115. Viatris Basic Information
Table 116. Viatris Long-acting Insulin Glargine Product Overview
Table 117. Viatris Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Viatris Business Overview
Table 119. Viatris Recent Developments
Table 120. Wockhardt Basic Information
Table 121. Wockhardt Long-acting Insulin Glargine Product Overview
Table 122. Wockhardt Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Wockhardt Business Overview
Table 124. Wockhardt Recent Developments
Table 125. Lupin Laboratories Basic Information
Table 126. Lupin Laboratories Long-acting Insulin Glargine Product Overview
Table 127. Lupin Laboratories Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Lupin Laboratories Business Overview
Table 129. Lupin Laboratories Recent Developments
Table 130. Cipla Basic Information
Table 131. Cipla Long-acting Insulin Glargine Product Overview
Table 132. Cipla Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Cipla Business Overview
Table 134. Cipla Recent Developments
Table 135. Global Long-acting Insulin Glargine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Long-acting Insulin Glargine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Long-acting Insulin Glargine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Long-acting Insulin Glargine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Long-acting Insulin Glargine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Long-acting Insulin Glargine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Long-acting Insulin Glargine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Long-acting Insulin Glargine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Long-acting Insulin Glargine Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Long-acting Insulin Glargine Market Size by Type (M USD)
Table 4. Global Long-acting Insulin Glargine Market Size by Application
Table 5. Long-acting Insulin Glargine Market Size Comparison by Region (M USD)
Table 6. Global Long-acting Insulin Glargine Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Long-acting Insulin Glargine Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Long-acting Insulin Glargine Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Long-acting Insulin Glargine Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Long-acting Insulin Glargine as of 2025)
Table 11. Global Market Long-acting Insulin Glargine Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers’ Manufacturing Sites, Areas Served
Table 13. Manufacturers’ Product Type
Table 14. Global Long-acting Insulin Glargine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Long-acting Insulin Glargine Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Long-acting Insulin Glargine Sales by Type (K MT)
Table 27. Global Long-acting Insulin Glargine Market Size by Type (M USD)
Table 28. Global Long-acting Insulin Glargine Sales (K MT) by Type (2020-2025)
Table 29. Global Long-acting Insulin Glargine Sales Market Share by Type (2020-2025)
Table 30. Global Long-acting Insulin Glargine Market Size (M USD) by Type (2020-2025)
Table 31. Global Long-acting Insulin Glargine Market Share by Type (2020-2025)
Table 32. Global Long-acting Insulin Glargine Price (USD/KG) by Type (2020-2025)
Table 33. Global Long-acting Insulin Glargine Sales (K MT) by Application
Table 34. Global Long-acting Insulin Glargine Market Size by Application
Table 35. Global Long-acting Insulin Glargine Sales by Application (2020-2025) & (K MT)
Table 36. Global Long-acting Insulin Glargine Sales Market Share by Application (2020-2025)
Table 37. Global Long-acting Insulin Glargine Market Size by Application (2020-2025) & (M USD)
Table 38. Global Long-acting Insulin Glargine Market Share by Application (2020-2025)
Table 39. Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
Table 40. Global Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 41. Global Long-acting Insulin Glargine Sales Market Share by Region (2020-2025)
Table 42. Global Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 43. Global Long-acting Insulin Glargine Market Size by Region (2020-2025)
Table 44. North America Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 45. North America Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 47. Europe Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 50. South America Long-acting Insulin Glargine Sales by Country (2020-2025) & (K MT)
Table 51. South America Long-acting Insulin Glargine Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Long-acting Insulin Glargine Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Long-acting Insulin Glargine Market Size by Region (2020-2025) & (M USD)
Table 54. Global Long-acting Insulin Glargine Production (K MT) by Region(2020-2025)
Table 55. Global Long-acting Insulin Glargine Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Long-acting Insulin Glargine Revenue Market Share by Region (2020-2025)
Table 57. Global Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Long-acting Insulin Glargine Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Sanofi Basic Information
Table 63. Sanofi Long-acting Insulin Glargine Product Overview
Table 64. Sanofi Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. Sanofi Business Overview
Table 66. Sanofi SWOT Analysis
Table 67. Sanofi Recent Developments
Table 68. Eli Lilly and Co Basic Information
Table 69. Eli Lilly and Co Long-acting Insulin Glargine Product Overview
Table 70. Eli Lilly and Co Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Eli Lilly and Co Business Overview
Table 72. Eli Lilly and Co SWOT Analysis
Table 73. Eli Lilly and Co Recent Developments
Table 74. Biocon Biologics Basic Information
Table 75. Biocon Biologics Long-acting Insulin Glargine Product Overview
Table 76. Biocon Biologics Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Biocon Biologics Business Overview
Table 78. Biocon Biologics SWOT Analysis
Table 79. Biocon Biologics Recent Developments
Table 80. Gan and Lee Basic Information
Table 81. Gan and Lee Long-acting Insulin Glargine Product Overview
Table 82. Gan and Lee Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. Gan and Lee Business Overview
Table 84. Gan and Lee Recent Developments
Table 85. Tonghua Dongbao Basic Information
Table 86. Tonghua Dongbao Long-acting Insulin Glargine Product Overview
Table 87. Tonghua Dongbao Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Tonghua Dongbao Business Overview
Table 89. Tonghua Dongbao Recent Developments
Table 90. Biocare Basic Information
Table 91. Biocare Long-acting Insulin Glargine Product Overview
Table 92. Biocare Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Biocare Business Overview
Table 94. Biocare Recent Developments
Table 95. United Laboratories Basic Information
Table 96. United Laboratories Long-acting Insulin Glargine Product Overview
Table 97. United Laboratories Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. United Laboratories Business Overview
Table 99. United Laboratories Recent Developments
Table 100. KALBE PHARMA Basic Information
Table 101. KALBE PHARMA Long-acting Insulin Glargine Product Overview
Table 102. KALBE PHARMA Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KALBE PHARMA Business Overview
Table 104. KALBE PHARMA Recent Developments
Table 105. Swixx Biopharma Basic Information
Table 106. Swixx Biopharma Long-acting Insulin Glargine Product Overview
Table 107. Swixx Biopharma Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 108. Swixx Biopharma Business Overview
Table 109. Swixx Biopharma Recent Developments
Table 110. INFION PHARMA Basic Information
Table 111. INFION PHARMA Long-acting Insulin Glargine Product Overview
Table 112. INFION PHARMA Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 113. INFION PHARMA Business Overview
Table 114. INFION PHARMA Recent Developments
Table 115. Viatris Basic Information
Table 116. Viatris Long-acting Insulin Glargine Product Overview
Table 117. Viatris Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 118. Viatris Business Overview
Table 119. Viatris Recent Developments
Table 120. Wockhardt Basic Information
Table 121. Wockhardt Long-acting Insulin Glargine Product Overview
Table 122. Wockhardt Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 123. Wockhardt Business Overview
Table 124. Wockhardt Recent Developments
Table 125. Lupin Laboratories Basic Information
Table 126. Lupin Laboratories Long-acting Insulin Glargine Product Overview
Table 127. Lupin Laboratories Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 128. Lupin Laboratories Business Overview
Table 129. Lupin Laboratories Recent Developments
Table 130. Cipla Basic Information
Table 131. Cipla Long-acting Insulin Glargine Product Overview
Table 132. Cipla Long-acting Insulin Glargine Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 133. Cipla Business Overview
Table 134. Cipla Recent Developments
Table 135. Global Long-acting Insulin Glargine Sales Forecast by Region (2026-2035) & (K MT)
Table 136. Global Long-acting Insulin Glargine Market Size Forecast by Region (2026-2035) & (M USD)
Table 137. North America Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 138. North America Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 139. Europe Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 140. Europe Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 141. Asia Pacific Long-acting Insulin Glargine Sales Forecast by Region (2026-2035) & (K MT)
Table 142. Asia Pacific Long-acting Insulin Glargine Market Size Forecast by Region (2026-2035) & (M USD)
Table 143. South America Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (K MT)
Table 144. South America Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 145. Middle East and Africa Long-acting Insulin Glargine Sales Forecast by Country (2026-2035) & (Units)
Table 146. Middle East and Africa Long-acting Insulin Glargine Market Size Forecast by Country (2026-2035) & (M USD)
Table 147. Global Long-acting Insulin Glargine Sales Forecast by Type (2026-2035) & (K MT)
Table 148. Global Long-acting Insulin Glargine Market Size Forecast by Type (2026-2035) & (M USD)
Table 149. Global Long-acting Insulin Glargine Price Forecast by Type (2026-2035) & (USD/KG)
Table 150. Global Long-acting Insulin Glargine Sales (K MT) Forecast by Application (2026-2035)
Table 151. Global Long-acting Insulin Glargine Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Long-acting Insulin Glargine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Insulin Glargine Market Size (M USD), 2025-2035
Figure 5. Global Long-acting Insulin Glargine Market Size (M USD) (2020-2035)
Figure 6. Global Long-acting Insulin Glargine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Insulin Glargine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting Insulin Glargine Product Life Cycle
Figure 13. Long-acting Insulin Glargine Sales Share by Manufacturers in 2025
Figure 14. Global Long-acting Insulin Glargine Revenue Share by Manufacturers in 2025
Figure 15. Long-acting Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Long-acting Insulin Glargine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting Insulin Glargine Revenue in 2025
Figure 18. Industry Chain Map of Long-acting Insulin Glargine
Figure 19. Global Long-acting Insulin Glargine Market PEST Analysis
Figure 20. Global Long-acting Insulin Glargine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting Insulin Glargine Market Share by Type
Figure 27. Sales Market Share of Long-acting Insulin Glargine by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting Insulin Glargine by Type in 2025
Figure 29. Market Share of Long-acting Insulin Glargine by Type (2020-2025)
Figure 30. Market Share of Long-acting Insulin Glargine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting Insulin Glargine Market Share by Application
Figure 33. Global Long-acting Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting Insulin Glargine Sales Market Share by Application in 2025
Figure 35. Global Long-acting Insulin Glargine Market Share by Application (2020-2025)
Figure 36. Global Long-acting Insulin Glargine Market Share by Application in 2025
Figure 37. Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting Insulin Glargine Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting Insulin Glargine Market Size by Region (2020-2025)
Figure 40. North America Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 43. North America Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting Insulin Glargine Market Size by Country in 2024
Figure 45. U.S. Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting Insulin Glargine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting Insulin Glargine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting Insulin Glargine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting Insulin Glargine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 53. Europe Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting Insulin Glargine Market Size by Country in 2024
Figure 55. Germany Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Long-acting Insulin Glargine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting Insulin Glargine Market Size by Region in 2024
Figure 68. China Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 79. South America Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 80. South America Long-acting Insulin Glargine Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting Insulin Glargine Market Size by Country in 2024
Figure 82. Brazil Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Long-acting Insulin Glargine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting Insulin Glargine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting Insulin Glargine Market Size by Region in 2024
Figure 92. Saudi Arabia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting Insulin Glargine Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Long-acting Insulin Glargine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Long-acting Insulin Glargine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Long-acting Insulin Glargine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Long-acting Insulin Glargine Market Share Forecast by Type (2026-2035)
Figure 111. Global Long-acting Insulin Glargine Sales Forecast by Application (2026-2035)
Figure 112. Global Long-acting Insulin Glargine Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Long-acting Insulin Glargine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Long-acting Insulin Glargine Market Size (M USD), 2025-2035
Figure 5. Global Long-acting Insulin Glargine Market Size (M USD) (2020-2035)
Figure 6. Global Long-acting Insulin Glargine Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Long-acting Insulin Glargine Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Long-acting Insulin Glargine Product Life Cycle
Figure 13. Long-acting Insulin Glargine Sales Share by Manufacturers in 2025
Figure 14. Global Long-acting Insulin Glargine Revenue Share by Manufacturers in 2025
Figure 15. Long-acting Insulin Glargine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Long-acting Insulin Glargine Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Long-acting Insulin Glargine Revenue in 2025
Figure 18. Industry Chain Map of Long-acting Insulin Glargine
Figure 19. Global Long-acting Insulin Glargine Market PEST Analysis
Figure 20. Global Long-acting Insulin Glargine Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Long-acting Insulin Glargine Market Share by Type
Figure 27. Sales Market Share of Long-acting Insulin Glargine by Type (2020-2025)
Figure 28. Sales Market Share of Long-acting Insulin Glargine by Type in 2025
Figure 29. Market Share of Long-acting Insulin Glargine by Type (2020-2025)
Figure 30. Market Share of Long-acting Insulin Glargine by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Long-acting Insulin Glargine Market Share by Application
Figure 33. Global Long-acting Insulin Glargine Sales Market Share by Application (2020-2025)
Figure 34. Global Long-acting Insulin Glargine Sales Market Share by Application in 2025
Figure 35. Global Long-acting Insulin Glargine Market Share by Application (2020-2025)
Figure 36. Global Long-acting Insulin Glargine Market Share by Application in 2025
Figure 37. Global Long-acting Insulin Glargine Sales Growth Rate by Application (2020-2025)
Figure 38. Global Long-acting Insulin Glargine Sales Market Share by Region (2020-2025)
Figure 39. Global Long-acting Insulin Glargine Market Size by Region (2020-2025)
Figure 40. North America Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 43. North America Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Long-acting Insulin Glargine Market Size by Country in 2024
Figure 45. U.S. Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Long-acting Insulin Glargine Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Long-acting Insulin Glargine Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Long-acting Insulin Glargine Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Long-acting Insulin Glargine Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 53. Europe Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Long-acting Insulin Glargine Market Size by Country in 2024
Figure 55. Germany Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Long-acting Insulin Glargine Sales Market Share by Region in 2024
Figure 67. Asia Pacific Long-acting Insulin Glargine Market Size by Region in 2024
Figure 68. China Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 79. South America Long-acting Insulin Glargine Sales Market Share by Country in 2024
Figure 80. South America Long-acting Insulin Glargine Market Size and Growth Rate (M USD)
Figure 81. South America Long-acting Insulin Glargine Market Size by Country in 2024
Figure 82. Brazil Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Long-acting Insulin Glargine Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Long-acting Insulin Glargine Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Long-acting Insulin Glargine Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Long-acting Insulin Glargine Market Size by Region in 2024
Figure 92. Saudi Arabia Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Long-acting Insulin Glargine Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Long-acting Insulin Glargine Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Long-acting Insulin Glargine Production Market Share by Region (2020-2025)
Figure 103. North America Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 106. China Long-acting Insulin Glargine Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Long-acting Insulin Glargine Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Long-acting Insulin Glargine Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Long-acting Insulin Glargine Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Long-acting Insulin Glargine Market Share Forecast by Type (2026-2035)
Figure 111. Global Long-acting Insulin Glargine Sales Forecast by Application (2026-2035)
Figure 112. Global Long-acting Insulin Glargine Market Share Forecast by Application (2026-2035)
